University of Birmingham – Drug Discovery Facility

The University of Birmingham is committed to being at the vanguard of academic-led drug discovery and the search for the next generation of therapies that will benefit humankind. Recently, the University of Birmingham has invested nearly three quarters of a million pounds to develop a High-Throughput Screening (HTS) facility. The Birmingham Drug Discovery Facility contains a number of cutting-edge technologies required to enable Birmingham scientists to conduct translational science.


Show full profile

Principal Disease Indication(s)

Infectious disease (Tuberculosis, Salmonella, S.aureus), Leukaemia and Lymphoma, HBV


Platform(s)

Small molecules


Technology(ies):

HTS plate reader


Funding sources:

MRC, Wellcome Trust and ERC


Personnel:

3


Number of Screens / year (any size):

5


Medicinal Chemistry Follow-up:

Yes


Contact Details

Dr Luke Alderwick

Phone:  Tel: +44 (0)121 414 5472
birmingham.ac.uk

Contact Form

To contact us, please fill in the form below


Getting there

Address: Birmingham, Birmingham, West Midlands B15, UK
X
- Enter Your Location -
- or -